Georges Weryha
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Georges Weryha has a total of 608 co-authors. Here are the top co-authors by number of shared publications:
M. Klein
21 shared publications- Jacques Leclere
Clinique Médicale et Endocrinologique, CHU de Nancy, Hôpital de Brabois, Nancy
19 shared publications M Klein
10 shared publications- Thomas Cuny
Department of Endocrinology, University Hospital, Nancy, France
10 shared publications - Laurent Brunaud
Département de chirurgie viscérale, métabolique et cancérologique, Inserm N-GERE, CHRU de Nancy, université de Lorraine, 54000 Nancy, France
8 shared publications M Duquenne
8 shared publications
Latest Publications
- 15 December 2018
- Published by Springer Nature in Calcified Tissue International
- Vol. 104 (4) , 355-363
Annual Injection of Zoledronic Acid Improves Bone Status in Children with Cerebral Palsy and Rett Syndrome
Osteoporosis is a common complication of cerebral palsy and Rett’s syndrome. It is responsible for multiple fractures, bone pain, and impaired quality of life. In case of Rett’s syndrome, a specific dysfunction of osteoblasts causes bone fragility. We observed the effects of annual zoledronic acid (ZA) infusion in a cohort of children with cerebral palsy and Rett’s syndrome. 27 children under 18 years (19 with cerebral palsy and 8 girls with Rett syndrome confirmed by MCEP2 mutation) were treated with an annual injection of 0.1 mg/kg (max 4 mg) of ZA. Calcium and vitamin D were combined in all patients from the first injection of ZA. Dental examination was performed before treatment. Data were analyzed retrospectively. Bone mineral density was measured at diagnosis and yearly thereafter. Bone mass density (BMD) is decreased in patient with cerebral palsy and RS. One year after injection of ZA, we observe an increase of Lumbar spine BMD from − 2.99 to − 2.14 SD (p < 0.0001) and femoral BMD from − 4.26 to − 3.32 SD (p < 0.001) In the subgroup of patient with Rett syndrome, we also observe an increase from − 3.27 to 2.50 SD (p = 0.018) of Lumbar spine BMD. No fractures have been observed in our cohort since the first infusion. Side effects (flu-like syndrome and hypocalcemia) were more common in younger patients and after the first infusion. No serious complications were noticed. This study confirms the efficacy and the safety of an annual injection of ZA to improve bone status in children with cerebral palsy and Rett syndrome. No severe adverse effects were observed.
- 15 December 2018
- Published by Springer Nature in Calcified Tissue International
- Vol. 104 (4) , 355-363
Annual Injection of Zoledronic Acid Improves Bone Status in Children with Cerebral Palsy and Rett Syndrome
Osteoporosis is a common complication of cerebral palsy and Rett’s syndrome. It is responsible for multiple fractures, bone pain, and impaired quality of life. In case of Rett’s syndrome, a specific dysfunction of osteoblasts causes bone fragility. We observed the effects of annual zoledronic acid (ZA) infusion in a cohort of children with cerebral palsy and Rett’s syndrome. 27 children under 18 years (19 with cerebral palsy and 8 girls with Rett syndrome confirmed by MCEP2 mutation) were treated with an annual injection of 0.1 mg/kg (max 4 mg) of ZA. Calcium and vitamin D were combined in all patients from the first injection of ZA. Dental examination was performed before treatment. Data were analyzed retrospectively. Bone mineral density was measured at diagnosis and yearly thereafter. Bone mass density (BMD) is decreased in patient with cerebral palsy and RS. One year after injection of ZA, we observe an increase of Lumbar spine BMD from − 2.99 to − 2.14 SD (p < 0.0001) and femoral BMD from − 4.26 to − 3.32 SD (p < 0.001) In the subgroup of patient with Rett syndrome, we also observe an increase from − 3.27 to 2.50 SD (p = 0.018) of Lumbar spine BMD. No fractures have been observed in our cohort since the first infusion. Side effects (flu-like syndrome and hypocalcemia) were more common in younger patients and after the first infusion. No serious complications were noticed. This study confirms the efficacy and the safety of an annual injection of ZA to improve bone status in children with cerebral palsy and Rett syndrome. No severe adverse effects were observed.
- 2 November 2018
- Published by Taylor & Francis in Growth Factors
- Vol. 36 (5-6) , 263-273
VEGF-A is associated with early degenerative changes in cartilage and subchondral bone
Paired cartilage and subchondral bone of subjects with no clinical history of joint disorders were analyzed to determine whether antioxidant enzymes, inflammatory cytokines and growth factors can be linked to a pre-osteoarthritis. Tissue explants were phenotyped according to Osteoarthritis Research Society International grading and micro-computed tomography, and also screened for the expression of several markers using quantitative polymerase chain reaction. The expression of these same genes was measured in SW1353 cells treated with hydrogen peroxide, to gain insight into the pathways involved with oxidative stress responses. Vascular endothelial growth factor A (VEGF-A) was up-regulated in the cartilage samples that showed early cartilage or bone degeneration. Oxidative stress in chondrocytes provoked up-regulation of interleukin-1β, interleukin-6, aggrecan, and SRY-box containing gene 9. Our results confirm the hitherto evidence of the deteriorating effects of the oxidative stress on cartilage and suggest the link between VEGF-A and pre-osteoarthritis.
- 2 November 2018
- Published by Taylor & Francis in Growth Factors
- Vol. 36 (5-6) , 263-273
VEGF-A is associated with early degenerative changes in cartilage and subchondral bone
Paired cartilage and subchondral bone of subjects with no clinical history of joint disorders were analyzed to determine whether antioxidant enzymes, inflammatory cytokines and growth factors can be linked to a pre-osteoarthritis. Tissue explants were phenotyped according to Osteoarthritis Research Society International grading and micro-computed tomography, and also screened for the expression of several markers using quantitative polymerase chain reaction. The expression of these same genes was measured in SW1353 cells treated with hydrogen peroxide, to gain insight into the pathways involved with oxidative stress responses. Vascular endothelial growth factor A (VEGF-A) was up-regulated in the cartilage samples that showed early cartilage or bone degeneration. Oxidative stress in chondrocytes provoked up-regulation of interleukin-1β, interleukin-6, aggrecan, and SRY-box containing gene 9. Our results confirm the hitherto evidence of the deteriorating effects of the oxidative stress on cartilage and suggest the link between VEGF-A and pre-osteoarthritis.
- Open Access
- 15 November 2017
- Published by Herald Scholarly Open Access in Human Endocrinology
- Vol. 2 (1) , 1-10
Impact of Parity on Fracture Risk after Menopause: A Systematic Review
Herald Scholarly Open Access publishes peer-reviewed scientific research which provides an immediate free access to articles. Herald Scholarly Open Access is publishing articles in 47 peer-reviewed Open Access journals in Biology, Medicine and Clinical sciences.
- 15 November 2017
- Published by Herald Scholarly Open Access in Human Endocrinology
- Vol. 2 (1) , 1-10
Open AccessImpact of Parity on Fracture Risk after Menopause: A Systematic Review
Herald Scholarly Open Access publishes peer-reviewed scientific research which provides an immediate free access to articles. Herald Scholarly Open Access is publishing articles in 47 peer-reviewed Open Access journals in Biology, Medicine and Clinical sciences.
- 1 September 2017
- Published by Elsevier in Annales d'Endocrinologie
- Vol. 78 (4) , 273
Une hypercalcémie peut en cacher une autre…
- 1 September 2017
- Published by Elsevier in Annales d'Endocrinologie
- Vol. 78 (4) , 273
Une hypercalcémie peut en cacher une autre…
- 1 February 2016
- Published by Elsevier in Annales d'Endocrinologie
- Vol. 77 (1) , 7-13
McCune–Albright syndrome, natural history and multidisciplinary management in a series of 14 pediatric cases
- 1 February 2016
- Published by Elsevier in Annales d'Endocrinologie
- Vol. 77 (1) , 7-13
McCune–Albright syndrome, natural history and multidisciplinary management in a series of 14 pediatric cases
- 1 February 2016
- Published by Elsevier in Annales d'Endocrinologie
- Vol. 77 (1) , 1-6
Thyroid side effects prophylaxis in front of nuclear power plant accidents
- 1 February 2016
- Published by Elsevier in Annales d'Endocrinologie
- Vol. 77 (1) , 1-6
Thyroid side effects prophylaxis in front of nuclear power plant accidents
- 1 December 2015
- Published by Elsevier in Annales d'Endocrinologie
- Vol. 76 (6) , 650-657
Efficacy and safety of denosumab for the treatment of osteoporosis: A systematic review
- 1 December 2015
- Published by Elsevier in Annales d'Endocrinologie
- Vol. 76 (6) , 650-657
Efficacy and safety of denosumab for the treatment of osteoporosis: A systematic review
- 1 December 2015
- Published by Oxford University Press (OUP) in European Journal of Endocrinology
- Vol. 173 (6) , 819-826
Unraveling the intrafamilial correlations and heritability of tumor types in MEN1: a Groupe d'étude des Tumeurs Endocrines study
Background: MEN1, which is secondary to the mutation of the MEN1 gene, is a rare autosomal-dominant disease that predisposes mutation carriers to endocrine tumors. Most studies demonstrated the absence of direct genotype-phenotype correlations. The existence of a higher risk of death in the Groupe d'étude des Tumeurs Endocrines-cohort associated with a mutation in the JunD interacting domain suggests heterogeneity across families in disease expressivity. This study aims to assess the existence of modifying genetic factors by estimating the intrafamilial correlations and heritability of the six main tumor types in MEN1.Methods: The study included 797 patients from 265 kindred and studied seven phenotypic criteria: parathyroid and pancreatic neuroendocrine tumors (NETs) and pituitary, adrenal, bronchial, and thymic (thNET) tumors and the presence of metastasis. Intrafamilial correlations and heritability estimates were calculated from family tree data using specific validated statistical analysis software.Results: Intrafamilial correlations were significant and decreased along parental degrees distance for pituitary, adrenal and thNETs. The heritability of these three tumor types was consistently strong and significant with 64% (s.e.m.=0.13; PPP=0.006) for thNETs.Conclusion: The present study shows the existence of modifying genetic factors for thymus, adrenal, and pituitary MEN1 tumor types. The identification of at-risk subgroups of individuals within cohorts is the first step toward personalization of care. Next generation sequencing on this subset of tumors will help identify the molecular basis of MEN1 variable genetic expressivity.
- 1 December 2015
- Published by Oxford University Press (OUP) in European Journal of Endocrinology
- Vol. 173 (6) , 819-826
Unraveling the intrafamilial correlations and heritability of tumor types in MEN1: a Groupe d'étude des Tumeurs Endocrines study
Background: MEN1, which is secondary to the mutation of the MEN1 gene, is a rare autosomal-dominant disease that predisposes mutation carriers to endocrine tumors. Most studies demonstrated the absence of direct genotype-phenotype correlations. The existence of a higher risk of death in the Groupe d'étude des Tumeurs Endocrines-cohort associated with a mutation in the JunD interacting domain suggests heterogeneity across families in disease expressivity. This study aims to assess the existence of modifying genetic factors by estimating the intrafamilial correlations and heritability of the six main tumor types in MEN1.Methods: The study included 797 patients from 265 kindred and studied seven phenotypic criteria: parathyroid and pancreatic neuroendocrine tumors (NETs) and pituitary, adrenal, bronchial, and thymic (thNET) tumors and the presence of metastasis. Intrafamilial correlations and heritability estimates were calculated from family tree data using specific validated statistical analysis software.Results: Intrafamilial correlations were significant and decreased along parental degrees distance for pituitary, adrenal and thNETs. The heritability of these three tumor types was consistently strong and significant with 64% (s.e.m.=0.13; PPP=0.006) for thNETs.Conclusion: The present study shows the existence of modifying genetic factors for thymus, adrenal, and pituitary MEN1 tumor types. The identification of at-risk subgroups of individuals within cohorts is the first step toward personalization of care. Next generation sequencing on this subset of tumors will help identify the molecular basis of MEN1 variable genetic expressivity.
- 1 October 2015
- Published by Elsevier in Joint Bone Spine
- Vol. 82 (5) , 320-325
Trabecular Bone Score: Where are we now?
- 1 October 2015
- Published by Elsevier in Joint Bone Spine
- Vol. 82 (5) , 320-325
Trabecular Bone Score: Where are we now?